Inventor
ZLOTNIK ALBERT
US44 patents
⚠️ This page may combine multiple inventors who share the name “ZLOTNIK ALBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
32 patentsUS7025962B1Apr 11, 2006
Mammalian cell surface antigens; related reagents
SCHERING CORP346 citations98
US6111090AAug 29, 2000
Mammalian cell surface antigens; related reagents
SCHERING CORP351 citations98
US6949243B1Sep 27, 2005
Methods of inhibiting metastasis
SCHERING CORP31 citations93
US5837232ANov 17, 1998
Use of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorder
SCHERING CORP30 citations92
US7115379B1Oct 3, 2006
Anti-mammalian CX3C cytokine antibodies
SCHERING CORP24 citations88
US6548654B1Apr 15, 2003
DNA encoding mammalian CX3C chemokine genes
SCHERING CORP13 citations83
US6645491B1Nov 11, 2003
Method for treating inflammatory conditions using an antibody to MIP-3α
SCHERING CORP14 citations80
US7279460B2Oct 9, 2007
Chemokine TECK polypeptides
SCHERING CORP7 citations73
US6723520B2Apr 20, 2004
Antibodies that bind chemokine teck
SCHERING CORP11 citations73
US5837293ANov 17, 1998
Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity
SCHERING CORP9 citations73
US7585502B2Sep 8, 2009
Mammalian CX3C chemokine antibodies
SCHERING CORP4 citations72
US5833976ANov 10, 1998
Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
SCHERING CORP9 citations72
US6566503B2May 20, 2003
Mammalian CX3C chemokine
SCHERING CORP11 citations71
US5858707AJan 12, 1999
Purified mammalian nucleobase permeases; nucleic acids; antibodies
SCHERING CORP10 citations71
US7101987B2Sep 5, 2006
CCL27 polypeptides
SCHERING CORP6 citations70
US5985580ANov 16, 1999
Antibodies which specifically bind to the thymokine lymphotactin
SCHERING CORP4 citations70
US5686257ANov 11, 1997
Binding compositions for mammalian T cell antigens and related reagents
SCHERING CORP8 citations69
US7431924B2Oct 7, 2008
Methods of treating inflammation using mammalian CX3C chemokine antibodies
SCHERING CORP7 citations68
US7521045B2Apr 21, 2009
Methods of inhibiting metastasis
SCHERING CORP3 citations63
US7276238B2Oct 2, 2007
Methods for using chemokine teck
SCHERING CORP2 citations62
US6022534AFeb 8, 2000
Lymphotactin uses
SCHERING CORP3 citations62
US7785804B2Aug 31, 2010
Mammalian CX3C chemokine antibodies
SCHERING CORP2 citations61
US6824781B2Nov 30, 2004
Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist
SCHERING CORP2 citations59
US6737252B2May 18, 2004
7 transmembrane receptor family member BLRX
SCHERING CORP4 citations59
US6245329B1Jun 12, 2001
Method of inducing calcium flux in cells using mammalian thymokine protein
SCHERING CORP3 citations59
US5877285AMar 2, 1999
Mammalian thymokine having leukocyte chemotactic activity, and fragments thereof
SCHERING CORP1 citations59
US5786210AJul 28, 1998
Mammalian thymokine genes
SCHERING CORP2 citations59
US8343492B2Jan 1, 2013
Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies
SCHERING CORP0 citations51
US6586217B1Jul 1, 2003
Mammalian selenophosphate synthetase
SCHERING CORP1 citations49
US7601815B2Oct 13, 2009
Anti-CCL27 antibodies
SCHERING CORP0 citations48
US6395268B1May 28, 2002
Lymphotactin uses
SCHERING CORP0 citations48
US7307146B2Dec 11, 2007
Dnaxccr10
SCHERING CORP0 citations47
SENOMYX INC
6 patentsUS7928111B2Apr 19, 2011
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
SENOMYX INC60 citations97
US9181276B2Nov 10, 2015
Modulation of chemosensory receptors and ligands associated therewith
SENOMYX INC26 citations91
US7932058B2Apr 26, 2011
Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
SENOMYX INC7 citations81
US10191050B2Jan 29, 2019
Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
SENOMYX INC0 citations49
US9739776B2Aug 22, 2017
Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
SENOMYX INC0 citations49
US9139867B2Sep 22, 2015
Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
SENOMYX INC0 citations49